Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Melanoma 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Carcinoma, Renal Cell 4Leukemia, Myeloid, Chronic-Phase 3Kidney Neoplasms 3Neoplasm Metastasis 2Lymphoma 2Leukemia 2Hepatitis B, Chronic 2Carcinoma, Hepatocellular 2Uveal Melanoma 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocytosis 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sezary Syndrome 1Recurrence 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neurofibroma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Mycosis Fungoides 1Meningeal Carcinomatosis 1

Interventions

Tenofovir 4peginterferon alfa-2b 2entecavir 2peginterferon alfa-2a 1ibrutinib 1durvalumab 1babao dan 1Radiofrequency Ablation 1Observation 1Nucleosides 1Methods 1Interferons 1Cholecalciferol 1Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hepatitis B, Chronic × peginterferon alfa-2b × Clear all
NCT07553767 2026-04-28

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

Ningbo No.2 Hospital

Phase EARLY_PHASE1 Not yet recruiting
156 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT05671315 2023-05-25

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

Ruijin Hospital

Phase NA Unknown
267 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡